(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-09 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 1107170
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Tue Jul 2024 | 3.40 | 3.24 | 3.41 | 3.24 | 0.915 times |
| 08 Mon Jul 2024 | 3.26 | 3.14 | 3.32 | 3.14 | 1.093 times |
| 05 Fri Jul 2024 | 3.12 | 3.15 | 3.15 | 3.05 | 0.599 times |
| 03 Wed Jul 2024 | 3.16 | 3.15 | 3.22 | 3.13 | 0.598 times |
| 03 Wed Jul 2024 | 3.16 | 3.15 | 3.22 | 3.13 | 0.598 times |
| 02 Tue Jul 2024 | 3.13 | 3.12 | 3.14 | 3.09 | 0.774 times |
| 01 Mon Jul 2024 | 3.12 | 3.07 | 3.15 | 3.05 | 0.652 times |
| 28 Fri Jun 2024 | 3.09 | 3.12 | 3.20 | 2.99 | 3.981 times |
| 27 Thu Jun 2024 | 3.10 | 3.03 | 3.14 | 3.03 | 0.582 times |
| 26 Wed Jun 2024 | 3.01 | 3.02 | 3.03 | 2.95 | 0.583 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 3.3, for a target of 3.2 or 3.12
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 2.30 |
| Downside Target | 2.42 |
| Downside Target | 2.63 |
| Downside Target | 2.81 |
| Downside Target | 2.92 |
| Downside Target | 3.05 |
| Downside Target | 3.14 |
| Downside Target | 3.22 |
| Downside Target | 3.29 |
| Upside Target | 3.41 |
| Upside Target | 3.44 |
| Upside Target | 3.64 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.22 |
| Downside Intraday Target | 3.05 |
| Upside Intraday Target | 3.49 |
| Upside Intraday Target | 3.59 |
| Downside Intraday Target | 3.32 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Tue Jul 2024 | 3.40 | 3.14 | 3.41 | 3.14 | 1.679 times |
| 05 Fri Jul 2024 | 3.12 | 3.15 | 3.22 | 3.05 | 0.591 times |
| 03 Wed Jul 2024 | 3.16 | 3.07 | 3.22 | 3.05 | 0.319 times |
| 28 Fri Jun 2024 | 3.09 | 3.09 | 3.20 | 2.95 | 1.714 times |
| 21 Fri Jun 2024 | 3.05 | 3.07 | 3.07 | 2.92 | 3.036 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Tue Jul 2024 | 3.40 | 3.07 | 3.41 | 3.05 | 0.245 times |
| 28 Fri Jun 2024 | 3.09 | 3.36 | 3.64 | 2.92 | 1.294 times |
| 31 Fri May 2024 | 3.36 | 2.74 | 3.44 | 2.63 | 0.418 times |
| 30 Tue Apr 2024 | 2.73 | 2.61 | 3.29 | 2.30 | 3.526 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arbutus Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.15 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arbutus Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.15 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.